A 34-year-old man from Delhi presents with a 3-year history of recurrent seizures occurring 2–3 times per month. Seizures begin with a rising epigastric sensation, followed by lip smacking, picking at clothes, and altered awareness lasting 60–90 seconds. He has no post-ictal confusion but feels tired for 30 minutes. Brain MRI shows a 1.5 cm lesion in the right mesial temporal lobe with T2 hyperintensity and hippocampal atrophy. He is currently on levetiracetam 1500 mg daily and lacosamide 200 mg daily, with breakthrough seizures persisting. What is the most appropriate next step in management?

Explanation

## Clinical Diagnosis This patient has **drug-resistant focal seizures** (temporal lobe epilepsy with mesial temporal sclerosis). He meets criteria for **refractory epilepsy**: failure of adequate trials of ≥2 antiepileptic drugs (AEDs). ## Definition of Drug-Resistant Epilepsy **Key Point:** Drug-resistant epilepsy is defined as failure to achieve sustained seizure freedom with adequate trials of at least 2 tolerated and appropriately chosen AED regimens (monotherapy or combination). This patient has already failed 2 agents (levetiracetam and lacosamide). ## Management Algorithm for Drug-Resistant Epilepsy ```mermaid flowchart TD A[Seizure recurrence on 2 AEDs]:::outcome --> B{Focal or generalized?}:::decision B -->|Focal + structural lesion on MRI| C[Candidate for surgery]:::action B -->|Generalized or no lesion| D[Add 3rd AED or device therapy]:::action C --> E[Presurgical evaluation]:::action E --> F[EEG, neuropsych testing, imaging]:::action F --> G[Surgical resection if localized focus]:::action G --> H[60-70% seizure-free post-op]:::outcome D --> I[VNS or RNS if not surgical candidate]:::action ``` ## Why Surgery Is Indicated Here | Criterion | This Patient | |-----------|---------------| | Focal seizure semiology | ✓ (temporal lobe features: epigastric aura, lip smacking, automatisms) | | Structural lesion on MRI | ✓ (mesial temporal sclerosis) | | Drug-resistant (≥2 AED failures) | ✓ (levetiracetam + lacosamide failed) | | Seizure frequency adequate for surgery | ✓ (2–3/month; surgery considered if ≥1/month) | | Age and cognitive status | ✓ (34 years old, no mention of cognitive decline) | **High-Yield:** Mesial temporal sclerosis (MTS) is the **most common surgically remediable cause of focal epilepsy**. Anterior temporal lobectomy (ATL) or selective amygdalohippocampectomy (SAH) achieves 60–70% seizure freedom and is the gold standard for drug-resistant temporal lobe epilepsy. ## Presurgical Workup 1. **Ictal/interictal EEG** — confirm unilateral temporal lobe focus 2. **Neuropsychological testing** — assess cognitive reserve and risk of post-operative deficits 3. **Structural MRI** — confirm lesion localization (already done) 4. **Functional imaging** (PET, fMRI) — optional, for lateralization **Clinical Pearl:** The 3-year duration and consistent focal semiology make this an ideal surgical candidate. Delaying surgery in drug-resistant epilepsy increases risk of sudden unexpected nocturnal death in epilepsy (SUDEP) and status epilepticus. ## Why Other Options Are Suboptimal **Warning:** Simply adding more AEDs (options A and D) delays definitive treatment. The probability of seizure freedom with a 3rd AED after 2 failures is only ~5–10%. Surgery offers 60–70% seizure-free rates and should not be postponed. [cite:Harrison 21e Ch 369; Robbins 10e Ch 28]